Ajmal Khan
Impact in
-
- Antibiotic Use and Resistance
- Drug Discovery top 5%
Papers in
- Pharmacology 31
- Cholinesterase and Neurodegenerative Diseases 14
- Pharmacological Effects of Medicinal Plants 10
-
- Synthesis and biological activity 20
- Co-authors
- Ahmed Al‐Harrasi (243 shared papers)Sobia Ahsan Halim (144 shared papers)Muhammad Iqbal Choudhary (32 shared papers)Najeeb Ur Rehman (65 shared papers)Abdur Rauf (31 shared papers)Javid Hussain (47 shared papers)Abdul Wadood (18 shared papers)René Csük (36 shared papers)
- Journals
- Bioorganic Chemistry (22 papers)ACS Omega (19 papers)Scientific Reports (16 papers)Medicinal Chemistry Research (15 papers)RSC Advances (15 papers)
- Partner nations
- PakistanOmanSaudi Arabia
In The Last Decade
Ajmal Khan
393 papers receiving 14.6k citations
Ajmal Khan's Hit Papers
Peers
Comparison fields: 5 of 158
- Applied Microbiology and Biotechnology 351
- Drug Discovery 5
- Endocrinology, Diabetes and Metabolism 1.0k
- Molecular Medicine 265
- Organic Chemistry 1.1k
Countries citing papers authored by Ajmal Khan
This map shows the geographic impact of Ajmal Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajmal Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajmal Khan more than expected).
Fields of papers citing papers by Ajmal Khan
This network shows the impact of papers produced by Ajmal Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajmal Khan. The network helps show where Ajmal Khan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ajmal Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 421 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 2997 |
| 2 | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Hit paper breakdown → | 2024 | 1965 |
| 3 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1712 |
| 4 | Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 318 |
| 5 | 2010 | 285 | |
| 6 | Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 207 |
| 7 | Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 191 |
| 8 | 2014 | 114 | |
| 9 | 2022 | 102 | |
| 10 | 2014 | 99 | |
| 11 | Synthesis, molecular docking and DFT analysis of novel bis-Schiff base derivatives with thiobarbituric acid for α-glucosidase inhibition assessment Hit paper breakdown → | 2024 | 89 |
| 12 | 2015 | 88 | |
| 13 | 2018 | 88 | |
| 14 | 2019 | 88 | |
| 15 | 2021 | 86 | |
| 16 | 2022 | 84 | |
| 17 | 2010 | 82 | |
| 18 | 2015 | 82 | |
| 19 | 2017 | 80 | |
| 20 | 2010 | 78 |
About Ajmal Khan
Ajmal Khan is a scholar working on Pharmacology, Organic Chemistry, Computational Theory and Mathematics, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 421 papers that have together received 15.0k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (22 papers), Synthesis and biological activity (20 papers), Enzyme function and inhibition (17 papers), Cholinesterase and Neurodegenerative Diseases (14 papers), Nanoparticles: synthesis and applications (12 papers), Pharmacological Effects of Medicinal Plants (10 papers), Natural Antidiabetic Agents Studies (10 papers) and Metal complexes synthesis and properties (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (351 citations), Drug Discovery (5 citations), Endocrinology, Diabetes and Metabolism (1.0k citations), Molecular Medicine (265 citations) and Organic Chemistry (1.1k citations). Ajmal Khan has collaborated with scholars based in Pakistan, Oman and Saudi Arabia. Frequent co-authors include Ahmed Al‐Harrasi, Sobia Ahsan Halim, Muhammad Iqbal Choudhary, Najeeb Ur Rehman, Abdur Rauf, Javid Hussain, Abdul Wadood, René Csük, Imtiaz Ali Khan and Khalid Mohammed Khan. Their work appears in journals such as Bioorganic Chemistry, ACS Omega, Scientific Reports, Medicinal Chemistry Research and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.